Belite Bio, Inc (BLTE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Belite Bio, Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -69.12x | -53.31x | -38.46x | -47.61x | -26.40x | -16.95x |
| P/B Ratio | 6.96x | 13.21x | 13.45x | 14.51x | -16.91x | -13.85x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 50.02x | 24.31x | 24.76x | 20.35x | 10.66x | 26.41x |
| Quick Ratio | 50.02x | 24.31x | 24.76x | 20.35x | 10.66x | 26.41x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.01x | 0.02x | -2.11x | -4.52x |
YoY = year-over-year change. Source: FMP..